428 related articles for article (PubMed ID: 22341440)
1. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
Hu J; Hwang SS; Liesa M; Gan B; Sahin E; Jaskelioff M; Ding Z; Ying H; Boutin AT; Zhang H; Johnson S; Ivanova E; Kost-Alimova M; Protopopov A; Wang YA; Shirihai OS; Chin L; DePinho RA
Cell; 2012 Feb; 148(4):651-63. PubMed ID: 22341440
[TBL] [Abstract][Full Text] [Related]
2. Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism.
Nitta E; Yamashita M; Hosokawa K; Xian M; Takubo K; Arai F; Nakada S; Suda T
Blood; 2011 Apr; 117(16):4169-80. PubMed ID: 21297001
[TBL] [Abstract][Full Text] [Related]
3. ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells.
Stohr BA; Blackburn EH
Cancer Res; 2008 Jul; 68(13):5309-17. PubMed ID: 18593932
[TBL] [Abstract][Full Text] [Related]
4. Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres.
Feldser D; Strong MA; Greider CW
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2249-51. PubMed ID: 16467146
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction in ataxia-telangiectasia.
Valentin-Vega YA; Maclean KH; Tait-Mulder J; Milasta S; Steeves M; Dorsey FC; Cleveland JL; Green DR; Kastan MB
Blood; 2012 Feb; 119(6):1490-500. PubMed ID: 22144182
[TBL] [Abstract][Full Text] [Related]
6. Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres.
Xu L; Blackburn EH
Mol Cell; 2007 Oct; 28(2):315-27. PubMed ID: 17964269
[TBL] [Abstract][Full Text] [Related]
7. Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation.
Qi L; Strong MA; Karim BO; Huso DL; Greider CW
Nat Cell Biol; 2005 Jul; 7(7):706-11. PubMed ID: 15965466
[TBL] [Abstract][Full Text] [Related]
8. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
Gocha ARS; Harris J; Groden J
Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
[TBL] [Abstract][Full Text] [Related]
9. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.
Wong KK; Maser RS; Bachoo RM; Menon J; Carrasco DR; Gu Y; Alt FW; DePinho RA
Nature; 2003 Feb; 421(6923):643-8. PubMed ID: 12540856
[TBL] [Abstract][Full Text] [Related]
10. Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition.
Bechter OE; Zou Y; Walker W; Wright WE; Shay JW
Cancer Res; 2004 May; 64(10):3444-51. PubMed ID: 15150096
[TBL] [Abstract][Full Text] [Related]
11. Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.
Ziv S; Brenner O; Amariglio N; Smorodinsky NI; Galron R; Carrion DV; Zhang W; Sharma GG; Pandita RK; Agarwal M; Elkon R; Katzin N; Bar-Am I; Pandita TK; Kucherlapati R; Rechavi G; Shiloh Y; Barzilai A
Hum Mol Genet; 2005 Oct; 14(19):2929-43. PubMed ID: 16150740
[TBL] [Abstract][Full Text] [Related]
12. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis.
Qi L; Strong MA; Karim BO; Armanios M; Huso DL; Greider CW
Cancer Res; 2003 Dec; 63(23):8188-96. PubMed ID: 14678974
[TBL] [Abstract][Full Text] [Related]
13. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
14. Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction.
Xue Y; Li L; Zhang D; Wu K; Chen Y; Zeng J; Wang X; He D
PLoS One; 2011; 6(11):e27748. PubMed ID: 22110753
[TBL] [Abstract][Full Text] [Related]
15. Telomere dysfunction induces metabolic and mitochondrial compromise.
Sahin E; Colla S; Liesa M; Moslehi J; Müller FL; Guo M; Cooper M; Kotton D; Fabian AJ; Walkey C; Maser RS; Tonon G; Foerster F; Xiong R; Wang YA; Shukla SA; Jaskelioff M; Martin ES; Heffernan TP; Protopopov A; Ivanova E; Mahoney JE; Kost-Alimova M; Perry SR; Bronson R; Liao R; Mulligan R; Shirihai OS; Chin L; DePinho RA
Nature; 2011 Feb; 470(7334):359-65. PubMed ID: 21307849
[TBL] [Abstract][Full Text] [Related]
16. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
17. Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis.
Eaton JS; Lin ZP; Sartorelli AC; Bonawitz ND; Shadel GS
J Clin Invest; 2007 Sep; 117(9):2723-34. PubMed ID: 17786248
[TBL] [Abstract][Full Text] [Related]
18. Telomeric recombination induced by dysfunctional telomeres.
Brault ME; Autexier C
Mol Biol Cell; 2011 Jan; 22(2):179-88. PubMed ID: 21118998
[TBL] [Abstract][Full Text] [Related]
19. Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas.
Winrow CJ; Pankratz DG; Vibat CR; Bowen TJ; Callahan MA; Warren AJ; Hilbush BS; Wynshaw-Boris A; Hasel KW; Weaver Z; Lockhart DJ; Barlow C
Hum Mol Genet; 2005 Sep; 14(18):2671-84. PubMed ID: 16087685
[TBL] [Abstract][Full Text] [Related]
20. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Flynn RL; Cox KE; Jeitany M; Wakimoto H; Bryll AR; Ganem NJ; Bersani F; Pineda JR; Suvà ML; Benes CH; Haber DA; Boussin FD; Zou L
Science; 2015 Jan; 347(6219):273-7. PubMed ID: 25593184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
